The clinical outcomes of ultra-low-dose radiotherapy for primary conjunctival mucosa-associated lymphoid tissue lymphoma

Violeta Filip P, Cuciureanu D, Sorina Diaconu L, Maria Vladareanu A, Silvia Pop C (2018) MALT lymphoma: epidemiology, clinical diagnosis and treatment. J Med Life 11(3):187–193. https://doi.org/10.25122/jml-2018-0035

Article  PubMed  PubMed Central  Google Scholar 

Kobayashi Y (2019) JSH practical guidelines for hematological malignancies, 2018. II. Lymphoma-2. Marginal zone lymphoma (MALT lymphoma/extranodal marginal zone lymphoma of mucosa-associated lymphoid tissue and splenic marginal zone lymphoma). Int J Hematol 110(4):393–405. https://doi.org/10.1007/s12185-019-02719-6

Article  PubMed  Google Scholar 

Holm F, Mikkelsen LH, Kamper P, Rasmussen PK, Larsen TS, Sjö LD, Heegaard S (2021) Ocular adnexal lymphoma in Denmark: a nationwide study of 387 cases from 1980 to 2017. Br J Ophthalmol 105(7):914–920. https://doi.org/10.1136/bjophthalmol-2019-315637

Article  PubMed  Google Scholar 

Kirkegaard MM, Rasmussen PK, Coupland SE, Esmaeli B, Finger PT, Graue GF, Grossniklaus HE, Honavar SG, Khong JJ, McKelvie PA, Mulay K, Prause JU, Ralfkiaer E, Sjö LD, Toft PB, Vemuganti GK, Thuro BA, Curtin J, Heegaard S (2016) Conjunctival lymphoma–an international multicenter retrospective study. JAMA Ophthalmol 134(4):406–414. https://doi.org/10.1001/jamaophthalmol.2015.6122

Article  PubMed  Google Scholar 

Niwa M, Ishikura S, Tatekawa K, Takama N, Miyakawa A, Kubota T, Kato E, Shibamoto Y (2020) Radiotherapy alone for stage IE ocular adnexal mucosa-associated lymphoid tissue lymphomas: long-term results. Radiat Oncol 15(1):25. https://doi.org/10.1186/s13014-020-1477-8

Article  CAS  PubMed  PubMed Central  Google Scholar 

Goda JS, Le LW, Lapperriere NJ, Millar BA, Payne D, Gospodarowicz MK, Wells W, Hodgson DC, Sun A, Simpson R, Tsang RW (2011) Localized orbital mucosa-associated lymphoma tissue lymphoma managed with primary radiation therapy: efficacy and toxicity. Int J Radiat Oncol Biol Phys 81(4):e659–e666. https://doi.org/10.1016/j.ijrobp.2011.03.050

Article  PubMed  Google Scholar 

Platt S, Al Zahrani Y, Singh N, Hill B, Cherian S, Singh AD (2017) Extranodal marginal zone lymphoma of ocular adnexa: outcomes following radiation therapy. Ocul Oncol Pathol 3(3):181–187. https://doi.org/10.1159/000453615

Article  PubMed  PubMed Central  Google Scholar 

Matsuo Y, Monden Y, Sasaki K, Akune H, Ikeda S, Ishio D, Murotani K, Nagafuji K, Yoshida S (2024) Treatment outcomes in patients with conjunctival mucosa-associated lymphoid tissue (MALT) lymphoma. Clin Ophthalmol 18:1999–2007. https://doi.org/10.2147/opth.S463653

Article  PubMed  PubMed Central  Google Scholar 

Min GJ, Kim SE, Kim TY, Jeon YW (2022) Long-term clinical outcomes in treatment-naïve patients with orbital adnexal mucosa-associated lymphoid tissue lymphoma: a single-center study. Front Oncol 12:769530. https://doi.org/10.3389/fonc.2022.769530

Article  CAS  PubMed  PubMed Central  Google Scholar 

Pinnix CC, Dabaja BS, Milgrom SA, Smith GL, Abou Z, Nastoupil L, Romaguera J, Turturro F, Fowler N, Fayad L, Westin J, Neelapu S, Fanale MA, Rodriguez MA, Hagemeister F, Lee HJ, Oki Y, Wang M, Samaniego F, Chi L, Esmaeli B (2017) Ultra–low-dose radiotherapy for definitive management of ocular adnexal B-cell lymphoma. Head Neck 39(6):1095–1100. https://doi.org/10.1002/hed.24717

Article  PubMed  PubMed Central  Google Scholar 

Lee MJ, Lee MY, Choe J-Y, Choi SH, Kim HJ (2021) Ultra-low-dose radiation treatment for early-stage ocular adnexal MALT lymphoma. Eur J Ophthalmol 32(5):3092–3096. https://doi.org/10.1177/11206721211035622

Article  PubMed  Google Scholar 

Yang X, Wang R, Yuan X, Yao S, Wang C, Cheng J (2022) Ultra-low-dose radiotherapy in the treatment of ocular adnexal lymphoma: a prospective study. Radiation Oncol. https://doi.org/10.1186/s13014-022-02180-6

Article  Google Scholar 

Manta AI, Schlect DJ, Wang DD, Sullivan TJ (2024) Two-year outcomes of ultra-low-dose radiotherapy in the treatment of ocular adnexal B-cell lymphomas. Ophthal Plast Reconstr Surg. https://doi.org/10.1097/iop.0000000000002747.DOI:10.1097/iop.0000000000002747

Cheson BD, Fisher RI, Barrington SF, Cavalli F, Schwartz LH, Zucca E, Lister TA (2014) Recommendations for initial evaluation, staging, and response assessment of Hodgkin and non-Hodgkin lymphoma: the Lugano classification. J Clin Oncol 32(27):3059–3068. https://doi.org/10.1200/jco.2013.54.8800

Article  PubMed  PubMed Central  Google Scholar 

Mizuhara K, Kobayashi T, Nakao M, Takahashi R, Kaneko H, Shimura K, Hirakawa K, Uoshima N, Wada K, Kawata E, Isa R, Fujino T, Tsukamoto T, Mizutani S, Shimura Y, Yoneda A, Watanabe A, Sotozono C, Kuroda J (2023) Watchful waiting is an acceptable treatment option for asymptomatic primary ocular adnexal mucosa-associated lymphoid tissue lymphoma: a retrospective study. Cancer Med 12(3):3134–3144. https://doi.org/10.1002/cam4.5237

Article  CAS  PubMed  Google Scholar 

Boltezar L, Strbac D, Pizem J, Hawlina G (2024) Ocular adnexal lymphoma—a retrospective study and review of the literature. Radiol Oncol 58(3):416–424. https://doi.org/10.2478/raon-2024-0048

Article  PubMed  PubMed Central  Google Scholar 

Nam SW, Woo KI, Kim YD (2018) Characteristics of primary extranodal marginal zone B-cell lymphoma in Korea: conjunctiva versus other ocular adnexa. Br J Ophthalmol 102(4):502–508. https://doi.org/10.1136/bjophthalmol-2017-310741

Article  PubMed  Google Scholar 

Saul EE, Alderuccio JP, Reis IM, Zhao W, Iyer SG, Rodriguez G, Desai A, Chapman JR, Tse DT, Markoe AM, Isrow DM, Lossos IS (2023) Long-term outcomes of patients with conjunctival extranodal marginal zone lymphoma. Am J Hematol 98(1):148–158. https://doi.org/10.1002/ajh.26591

Article  PubMed  Google Scholar 

Fukutsu K, Kase S, Ishijima K, Kinoshita R, Ishida S (2018) The clinical features of radiation cataract in patients with ocular adnexal mucosa-associated lymphoid tissue lymphoma. Radiat Oncol 13(1):95. https://doi.org/10.1186/s13014-018-1045-7

Article  CAS  PubMed  PubMed Central  Google Scholar 

Harada K, Murakami N, Kitaguchi M, Sekii S, Takahashi K, Yoshio K, Inaba K, Morota M, Ito Y, Sumi M, Suzuki S, Tobinai K, Uno T, Itami J (2014) Localized ocular adnexal mucosa-associated lymphoid tissue lymphoma treated with radiation therapy: a long-term outcome in 86 patients with 104 treated eyes. Int J Radiat Oncol Biol Phys 88(3):650–654. https://doi.org/10.1016/j.ijrobp.2013.11.235

Article  PubMed  Google Scholar 

Jeon YW, Yang HJ, Choi BO, Jung SE, Park KS (2018) Comparison of selection and long-term clinical outcomes between chemotherapy and radiotherapy as primary therapeutic modality for ocular adnexal MALT Lymphoma. EClinicalMedicine 4:32–42. https://doi.org/10.1016/j.eclinm.2018.10.001

Article  PubMed  Google Scholar 

Eze C, Friedrich I, Hadi I, Schmidt-Hegemann NS, Hartoyo SN, Trauth R, Reitz D, Manapov F, Siefert A, Dreyling M, Belka C, Li M (2022) Primary radiation therapy in stage I/II indolent orbital lymphoma - a comprehensive retrospective recurrence and toxicity analysis. Eur J Haematol 109(1):21–30. https://doi.org/10.1111/ejh.13765

Article  CAS  PubMed  Google Scholar 

Nuzzi R, Trossarello M, Bartoncini S, Marolo P, Franco P, Mantovani C, Ricardi U (2020) Ocular complications after radiation therapy: an observational study. Clin Ophthalmol 14:3153–3166. https://doi.org/10.2147/opth.S263291

Article  CAS  PubMed  PubMed Central  Google Scholar 

Comments (0)

No login
gif